An assessment of sustained efficacy and safety of a 300IR five-grass pollen sublingual immunotherapy tablet in adults with grass pollen induced allergic rhinoconjunctivitis during a 3-year treatment study

作者:Didier A; Horak F; Worm M; Melac M; de Beaumont O; Le Gall M; Montagut A; Galvain S; Malling H
来源:29th Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI), 2010-06-05 to 2010-06-09.
  • 出版日期2010-6